Prospective randomization of post-remission therapy comparing autologous peripheral blood stem cell transplantation versus high-dose cytarabine consolidation for acute myelogenous leukemia in first remission
Crossref DOI link: https://doi.org/10.1007/s12185-017-2389-8
Published Online: 2017-12-14
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Miyamoto, Toshihiro
,
Nagafuji, Koji
Fujisaki, Tomoaki
Uchida, Naoyuki
Matsue, Kosei
Henzan, Hideho
Ogawa, Ryosuke
Takase, Ken
Aoki, Takatoshi
Hidaka, Michihiro
Teshima, Takanori
Taniguchi, Shuichi
Akashi, Koichi
Harada, Mine
License valid from 2017-12-14